Eli Lilly and Company (SWX:LLY)
625.00
+5.00 (0.81%)
At close: Jul 16, 2025
Eli Lilly and Company Revenue
Eli Lilly and Company had revenue of $12.73B USD in the quarter ending March 31, 2025, with 45.17% growth. This brings the company's revenue in the last twelve months to $49.00B, up 36.38% year-over-year. In the year 2024, Eli Lilly and Company had annual revenue of $45.04B with 32.00% growth.
Revenue (ttm)
$49.00B
Revenue Growth
+36.38%
P/S Ratio
13.05
Revenue / Employee
$1.04M
Employees
47,000
Market Cap
565.29B CHF
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 45.04B | 10.92B | 32.00% |
Dec 31, 2023 | 34.12B | 5.58B | 19.56% |
Dec 31, 2022 | 28.54B | 223.00M | 0.79% |
Dec 31, 2021 | 28.32B | 3.78B | 15.40% |
Dec 31, 2020 | 24.54B | 2.22B | 9.95% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Roche Holding AG | 62.40B |
Novartis AG | 47.05B |
Lonza Group AG | 6.57B |
Alcon | 8.77B |
Galderma Group AG | 4.02B |
Sandoz Group AG | 9.41B |
Straumann Holding AG | 2.50B |
Sonova Holding AG | 3.87B |
Eli Lilly and Company News
- 20 hours ago - Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly's Zepbound - CNBC
- 1 day ago - Eli Lilly (LLY) Gains Canadian Approval for Crohn's Disease Drug Omvoh - GuruFocus
- 1 day ago - How Do Investors Really Feel About Eli Lilly? - Benzinga
- 1 day ago - Eli Lilly: Still Too Pricey To Buy - Seeking Alpha
- 1 day ago - Tech drives gains: NVDA and AMD lead the charge while healthcare faces setbacks - Forexlive
- 2 days ago - Eli Lilly's Omvoh wins Health Canada approval for Crohn’s disease - Seeking Alpha
- 3 days ago - How To Trade This 150% Gainer Chasing A Cure For Type 1 Diabetes - Benzinga
- 3 days ago - This Is 'One Of The Hottest Stocks In The Universe,' Jim Cramer Says - Benzinga